Jalaja Potluri, MD of AbbVie Inc. discusses what’s next for her study and her hopes for the drug to become FDA approved. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Jalaja Potluri, MD of AbbVie Inc. discusses what’s next for her study and her hopes for the drug to become FDA approved. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.